Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 144, Issue 1-2, Pages 132-138Publisher
ELSEVIER
DOI: 10.1016/j.jneuroim.2003.08.033
Keywords
Trypanosoma brucei gambiense; cerebrospinal fluid; Pentamidine; intrathecal humoral immune response; IgM; treatment failure; card agglutination
Categories
Ask authors/readers for more resources
In a clinical trial on efficacy of Pentamidine in second stage Trypanosoma brucei gambiense patients with less than or equal to 20 cells/mul in cerebrospinal fluid (CSF), 43% of treatment failures were observed. We hypothesised that unsuccessful treatment was caused by uncured brain infection. The relationship between treatment outcome and CSF cell count, protein concentration, presence of trypanosomes, the intrathecal immune response, and CSF total IgM and trypanosome specific antibodies detected by LATEX/IgM and LATEX/Tb. gambiense card agglutination tests was examined. Cell counts of 11-20 cells/mul, intrathecal IgM synthesis, CSF end-titres in LATEX/IgM greater than or equal to 4 and LATEX/Tb. gambiense positive CSF, were associated with treatment failure. Detection of intrathecal IgM synthesis is valuable for assessment of brain involvement and treatment decision. (C) 2003 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available